Guardant Health, Inc.
NASDAQ:GHMedical - Diagnostics & Research
+$2.67 today
- Market cap
- $19.64B
- Beta
- 1.62
- P/E (TTM)
- -39.9
- EPS (TTM)
- -$3.30
Volume 1.50M
Average 2.21M
GH Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Guardant Health, Inc.NASDAQ: GH
Other Current Liabilities · Q3 FY2026 · quarter ended Sep 2026
Other current liabilities remains negative
Q3 FY2026 other current liabilities was $0, compared with $98.21M a year earlier. Over 3 fiscal years it compounded at +29.0% a year.
Context
- Other current liabilities amounted to 0.0% of total assets at the end of Q3 FY2026, down 7.7 pp from a year earlier.
- Other current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 119.65M USD
- Year-over-year change
- +43.8%
- 4-year CAGR
- -0.2%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 119.65M | +43.8% |
| FY2024 | 2024-12-31 | 83.22M | +14.4% |
| FY2023 | 2023-12-31 | 72.74M | +30.4% |
| FY2022 | 2022-12-31 | 55.79M | -53.7% |
| FY2021 | 2021-12-31 | 120.5M | — |
Other Current Liabilities vs competitors
How GH compares with its peers on the latest reported figures
- GH's Sep 2026 other current liabilities of $0 is the 9th highest of the 10 companies compared; the peer median is $19.04M.
- Its year-over-year change of -100.0% is the 9th highest of 10, against a peer median of +48.4%.
- Other current liabilities amounts to 0.0% of total assets for GH, versus a peer median of 4.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $115.58M | +78.6% | +17.5% | 4.3% | |
| Mar 2026 | $90.5M | +79.2% | +14.3% | 13.4% | |
| Mar 2026 | $53.65M | +775.7% | +25.4% | 4.6% | |
| Mar 2026 | $24.08M | +26.5% | +18.1% | 4.4% | |
BLLNBillionToOne, Inc. | Jun 2026 | $19.04M | +69.4% | — | 2.6% |
| Mar 2026 | $11.29M | +48.4% | +10.2% | 3.5% | |
| Mar 2026 | $6.46M | +18.5% | -16.3% | 6.8% | |
| Jun 2026 | $1.11M | -95.4% | -0.0% | 0.0% | |
| Sep 2026 | $0 | -100.0% | +29.0% | 0.0% | |
| Jun 2026 | $0 | -100.0% | +58.9% | 0.0% | |
| Peer median (excluding GH) | $19.04M | +48.4% | +15.9% | 4.3% | |
Competitors are the stored peer set for GH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 492.2M | 141.65M | 1.13B | 525.54M | 378.2M |
| Short-term Investments | 440.55M | 869.58M | 35.1M | 314.44M | 823.4M |
| Net Receivables | 97.65M | 97.26M | 88.78M | 110.25M | 137.85M |
| Inventory | 30.67M | 51.6M | 61.95M | 71.08M | 85.88M |
| Other Current Assets | 0 | 31.51M | 27.74M | 33.8M | 40.72M |
| Total Current Assets | 1.11B | 1.19B | 1.35B | 1.06B | 1.47B |
| Property, Plant & Equipment (Net) | 313.9M | 341.92M | 302.71M | 279.08M | 304.76M |
| Goodwill | 3.29M | 3.29M | 3.29M | 3.29M | 77.26M |
| Intangible Assets | 14.21M | 11.73M | 8.98M | 6.76M | 25.92M |
| Long-term Investments | 698.03M | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 60.94M | 61.45M | 124.33M | 141.37M | 139.67M |
| Total Non-current Assets | 1.09B | 418.39M | 439.32M | 430.5M | 547.61M |
| Total Assets | 2.2B | 1.61B | 1.79B | 1.49B | 2.01B |
| Account Payables | 38.52M | 68.91M | 51.74M | 38.55M | 54.44M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 4.22M | 0 | 0 | 0 | 0 |
| Deferred Revenue | 11.33M | 17.4M | 17.97M | 35.47M | 50.75M |
| Other Current Liabilities | 120.5M | 55.79M | 72.74M | 83.22M | 119.65M |
| Total Current Liabilities | 194.69M | 193.22M | 205.92M | 225.58M | 302.73M |
| Long-term Debt | 1.13B | 1.14B | 1.14B | 1.14B | 1.5B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 3.93M | 9.18M | 96.01M | 92.83M | 127.77M |
| Total Non-current Liabilities | 1.36B | 1.36B | 1.42B | 1.4B | 1.81B |
| Total Liabilities | 1.56B | 1.55B | 1.63B | 1.63B | 2.11B |
| Common Stock | 1K | 1K | 1K | 1K | 1K |
| Retained Earnings | (1.01B) | (1.66B) | (2.14B) | (2.58B) | (2.99B) |
| Accumulated OCI | (4.76M) | (19.52M) | (3.68M) | (5.2M) | (4.85M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 645.01M | 60.18M | 158.68M | (139.65M) | (99.31M) |
| Total Debt | 1.37B | 1.37B | 1.35B | 1.34B | 1.71B |
| Net Debt | 881.53M | 1.23B | 220.23M | 810.51M | 1.33B |
Guardant Health, Inc.
NASDAQ:GH
Intrinsic Alpha fair value
Locked
Current Price
$145.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.